お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
1006210

自己注射の世界市場:タイプ別、用法別、アプリケーション別、流通チャネル別の予測(2026年まで)- COVID-19の累積的影響

Self-injections Market Research Report by Type, by Usage, by Application, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.33円
自己注射の世界市場:タイプ別、用法別、アプリケーション別、流通チャネル別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の自己注射の市場規模は、2020年の369億8,724万米ドルから2025年末までに598億7,051万米ドルに拡大すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた未曾有の世界の公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されています。当レポートでは、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げ消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19の影響について考察しています。

当レポートは、世界の自己注射市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、タイプ・用法・アプリケーション・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • ステークホルダー

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査器具
    • 収集:データソース
    • 分析:データ解釈
    • 策定:データ検証
    • 発行:調査報告書
    • 繰り返し:レポートの更新
  • 調査の実施
    • 開始:調査プロセス
    • 計画:調査計画の策定
    • 実行:調査の実施
    • 検証:発見と分析
    • 発行:調査報告書
  • 調査の成果

第3章 エグゼクティブサマリー

  • 市場展望
  • タイプ別市場の展望
  • 用法別市場の展望
  • アプリケーション別市場の展望
  • 流通チャネル別市場の展望
  • 地域別市場の展望
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 タイプ別の自己注射市場

  • オートインジェクター
  • 無針注射器
  • ペンインジェクター
  • ウェアラブルインジェクター

第7章 自己注射市場、用法別

  • 使い捨て
  • 再利用可能

第8章 アプリケーション別の自己注射市場

  • 自己免疫疾患
  • ホルモン障害
  • 希少疾患
  • 呼吸療法

第9章 流通チャネル別の自己注射市場

  • 病院薬局
  • オンライン薬局
  • 個人診療所

第10章 南北アメリカの自己注射市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の自己注射市場

  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第12章 欧州、中東・アフリカの自己注射市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、パートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第14章 企業プロファイル

  • 3M Company
  • Abbvie Inc.
  • Antares Pharma, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bespak Europe Ltd.
  • Credence MedSystems, Inc.
  • Eli Lilly and Company
  • Gerresheimer AG
  • Insulet Corporation
  • Owen Mumford Ltd
  • Penjet Corporation
  • Pfizer Inc.
  • PharmaJet, Inc.
  • Recipharm AB
  • SCHOTT AG
  • SHL Group
  • Sulzer AG
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
  • Ypsomed AG

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格
  • 連絡先の詳細
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL SELF-INJECTIONS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 7. GLOBAL SELF-INJECTIONS MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL SELF-INJECTIONS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2026
  • FIGURE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2026
  • FIGURE 23. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 28. GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 30. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 31. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2026 (USD BILLION)
  • FIGURE 33. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONAL DISORDERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 34. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ORPHAN DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 35. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ORPHAN DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 36. GLOBAL SELF-INJECTIONS MARKET SIZE, BY RESPIRATORY THERAPY, 2018-2026 (USD BILLION)
  • FIGURE 37. GLOBAL SELF-INJECTIONS MARKET SIZE, BY RESPIRATORY THERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 38. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
  • FIGURE 39. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
  • FIGURE 41. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, 2018-2026 (USD BILLION)
  • FIGURE 46. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. AMERICAS SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 48. AMERICAS SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 50. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. BRAZIL SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. CANADA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. MEXICO SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. CALIFORNIA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. FLORIDA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. ILLINOIS SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. NEW YORK SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. OHIO SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. PENNSYLVANIA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. TEXAS SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 63. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 65. CHINA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. INDIA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. INDONESIA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. JAPAN SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. THAILAND SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 74. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 76. FRANCE SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. GERMANY SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 78. ITALY SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 80. QATAR SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 81. RUSSIA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 82. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 83. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 84. SPAIN SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 85. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 86. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 87. GLOBAL SELF-INJECTIONS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 88. GLOBAL SELF-INJECTIONS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 89. GLOBAL SELF-INJECTIONS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 90. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SELF-INJECTIONS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL SELF-INJECTIONS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONAL DISORDERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ORPHAN DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY RESPIRATORY THERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. AMERICAS SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. AMERICAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. AMERICAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. AMERICAS SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. AMERICAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. BRAZIL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. BRAZIL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. BRAZIL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. BRAZIL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. CANADA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. CANADA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. CANADA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. CANADA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. MEXICO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. MEXICO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. MEXICO SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. MEXICO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. CALIFORNIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. CALIFORNIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. CALIFORNIA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. CALIFORNIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. FLORIDA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. FLORIDA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. FLORIDA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. FLORIDA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. ILLINOIS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. ILLINOIS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. ILLINOIS SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. ILLINOIS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. NEW YORK SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. NEW YORK SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. NEW YORK SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. NEW YORK SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. OHIO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. OHIO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. OHIO SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. OHIO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. PENNSYLVANIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. PENNSYLVANIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. PENNSYLVANIA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. PENNSYLVANIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. TEXAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. TEXAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. TEXAS SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. TEXAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. CHINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. CHINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. CHINA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. CHINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. INDIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. INDIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. INDIA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. INDIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. INDONESIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. INDONESIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. INDONESIA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. INDONESIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. JAPAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. JAPAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. JAPAN SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. JAPAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. THAILAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. THAILAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. THAILAND SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. THAILAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. FRANCE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. FRANCE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. FRANCE SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. FRANCE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. GERMANY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. GERMANY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. GERMANY SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 123. GERMANY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 124. ITALY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 125. ITALY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 126. ITALY SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 127. ITALY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 128. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 129. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 130. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 131. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 132. QATAR SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 133. QATAR SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 134. QATAR SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 135. QATAR SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 136. RUSSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 137. RUSSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 138. RUSSIA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 139. RUSSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 140. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 141. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 142. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 143. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 144. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 145. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 146. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 147. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 148. SPAIN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 149. SPAIN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 150. SPAIN SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 151. SPAIN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 152. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 153. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 154. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 155. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 156. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 157. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 158. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 159. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 160. GLOBAL SELF-INJECTIONS MARKET: SCORES
  • TABLE 161. GLOBAL SELF-INJECTIONS MARKET: BUSINESS STRATEGY
  • TABLE 162. GLOBAL SELF-INJECTIONS MARKET: PRODUCT SATISFACTION
  • TABLE 163. GLOBAL SELF-INJECTIONS MARKET: RANKING
  • TABLE 164. GLOBAL SELF-INJECTIONS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 165. GLOBAL SELF-INJECTIONS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 166. GLOBAL SELF-INJECTIONS MARKET: MERGER & ACQUISITION
  • TABLE 167. GLOBAL SELF-INJECTIONS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 168. GLOBAL SELF-INJECTIONS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 169. GLOBAL SELF-INJECTIONS MARKET: INVESTMENT & FUNDING
  • TABLE 170. GLOBAL SELF-INJECTIONS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 171. GLOBAL SELF-INJECTIONS MARKET: LICENSE & PRICING
  • TABLE 172. GLOBAL SELF-INJECTIONS MARKET: CONTACT DETAILS
目次
Product Code: MRR-03050D1B2DB5

The Global Self-injections Market size was estimated at USD 36.98 Billion in 2020 and expected to reach USD 40.91 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 10.94% to reach USD 68.99 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Self-injections to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Self-injections Market was studied across Auto-Injectors, Needle-free Injectors, Pen Injectors, and Wearable Injectors.

Based on Usage, the Self-injections Market was studied across Disposable and Reusable.

Based on Application, the Self-injections Market was studied across Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, and Respiratory Therapy.

Based on Distribution Channel, the Self-injections Market was studied across Hospital Pharmacies, Online Pharmacies, and Private Clinics.

Based on Geography, the Self-injections Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Self-injections Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Self-injections Market, including 3M Company, Abbvie Inc., Antares Pharma, Inc., Baxter International Inc., Becton, Dickinson and Company, Bespak Europe Ltd., Credence MedSystems, Inc., Eli Lilly and Company, Gerresheimer AG, Insulet Corporation, Owen Mumford Ltd, Penjet Corporation, Pfizer Inc., PharmaJet, Inc., Recipharm AB, SCHOTT AG, SHL Group, Sulzer AG, Terumo Corporation, West Pharmaceutical Services, Inc., Wilhelm Haselmeier GmbH & Co. KG, and Ypsomed AG.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Self-injections Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Self-injections Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Self-injections Market?
  • 4. What is the competitive strategic window for opportunities in the Global Self-injections Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Self-injections Market?
  • 6. What is the market share of the leading vendors in the Global Self-injections Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Self-injections Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Type Outlook
  • 3.4. Usage Outlook
  • 3.5. Application Outlook
  • 3.6. Distribution Channel Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid prevalence of chronic diseases prominently diabetes and rheumatoid arthritis
      • 5.1.1.2. Technological advancement acquired by pharmaceutical companies
      • 5.1.1.3. Low cost, easy use and patent expiry of biological drugs and demand for biosimilars
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulation for patent approval and lack of awareness
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of biologic drugs to treat autoimmune disease
      • 5.1.3.2. Worldwide increase in diabetes and the growing pressure on health care costs
    • 5.1.4. Challenges
      • 5.1.4.1. Growing use of alternative delivery methods
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Self-injections Market, by Type

  • 6.1. Introduction
  • 6.2. Auto-Injectors
  • 6.3. Needle-free Injectors
  • 6.4. Pen Injectors
  • 6.5. Wearable Injectors

7. Self-injections Market, by Usage

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Self-injections Market, by Application

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Hormonal Disorders
  • 8.4. Orphan Diseases
  • 8.5. Respiratory Therapy

9. Self-injections Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Private Clinics

10. Americas Self-injections Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific Self-injections Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Self-injections Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. 3M Company
  • 14.2. Abbvie Inc.
  • 14.3. Antares Pharma, Inc.
  • 14.4. Baxter International Inc.
  • 14.5. Becton, Dickinson and Company
  • 14.6. Bespak Europe Ltd.
  • 14.7. Credence MedSystems, Inc.
  • 14.8. Eli Lilly and Company
  • 14.9. Gerresheimer AG
  • 14.10. Insulet Corporation
  • 14.11. Owen Mumford Ltd
  • 14.12. Penjet Corporation
  • 14.13. Pfizer Inc.
  • 14.14. PharmaJet, Inc.
  • 14.15. Recipharm AB
  • 14.16. SCHOTT AG
  • 14.17. SHL Group
  • 14.18. Sulzer AG
  • 14.19. Terumo Corporation
  • 14.20. West Pharmaceutical Services, Inc.
  • 14.21. Wilhelm Haselmeier GmbH & Co. KG
  • 14.22. Ypsomed AG

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.